Vasculogenic mimicry: A new prognostic sign of human osteosarcoma

Human Pathology

Volumn 45, Issue 10, 2014, Pages 2120-2129

  Ren, Ke ^a   Yao, Nan ^b   Wang, Guangye ^c   Tian, Lei ^d   Ma, Jie ^e   Shi, Xin ^e   Zhang, Lei ^a   Zhang, Jian ^b   Zhou, Xing ^e   Zhou, Guangxin ^e   Wu, Sujia ^e   Sun, Xiaoliang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Jiangsu Province Academy of Traditional Chinese Medicine   (China)

^c The Second People's Hospital of Wuhu   (China)

^d AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e NANJING UNIVERSITY   (China)

Author keywords

Focal adhesion kinase; Migration inducting gene 7; Osteosarcoma; Survival; Vasculogenic mimicry

Indexed keywords

CD34 ANTIBODY; FOCAL ADHESION KINASE; MEMBRANE PROTEIN; MIGRATION INDUCING GENE 7 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; NEOVASCULARIZATION (PATHOLOGY); OSTEOSARCOMA; OVERALL SURVIVAL; PERIODIC ACID SCHIFF STAIN; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR VOLUME; VASCULOGENIC MIMICRY; VERY ELDERLY; ADOLESCENT; BONE TUMOR; CHILD; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 84908176539     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.06.013     Document Type: Article

References (35)

1. P.J. Messerschmitt, R.M. Garcia, and F.W. Abdul-Karim Osteosarcoma J Am Acad Orthop Surg 17 2009 515 527
2. A.J. Maniotis, R. Folberg, and A. Hess Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am J Pathol 155 1999 739 752
3. R. Folberg, M.J. Hendrix, and A.J. Maniotis Vasculogenic mimicry and tumor angiogenesis Am J Pathol 156 2000 361 381
4. R. Folberg, and A.J. Maniotis Vasculogenic mimicry APMIS 112 2004 508 525
5. B. Sun, S. Zhang, and D. Zhang Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma Oncol Rep 16 2006 693 698
6. B. Sun, S. Qie, and S. Zhang Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors Hum Pathol 39 2008 846 856
7. Y.Z. Fan, and W. Sun Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy World J Gastrointest Surg 2 2010 117 127
8. G.P. Robertson Mig-7 linked to vasculogenic mimicry Am J Pathol 170 2007 1454 1456
9. A.R. Hess, and M.J. Hendrix Focal adhesion kinase signaling and the aggressive melanoma phenotype Cell Cycle 5 2006 478 480
10. A.P. Petty, K.L. Garman, and V.D. Winn Overexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formation Am J Pathol 170 2007 1763 1780
11. A.P. Petty, S.E. Wright, and K.A. Rewers-Felkins Targeting migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activity Mol Cancer Ther 8 2009 2412 2423
12. G. Bacci, S. Ferrari, and F. Bertoni Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: an updated report J Clin Oncol 18 2000 4016 4027
13. P. Bhat, F.A. Jakobiec, and R. Folberg Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas Semin Ophthalmol 24 2009 166 171
14. X.M. Liu, Q.P. Zhang, and Y.G. Mu Clinical significance of vasculogenic mimicry in human gliomas J Neurooncol 105 2011 173 179
15. M.Y. Ho, S.M. Liang, and S.W. Hung MIG-7 controls COX-2/PGE2-mediated lung cancer metastasis Cancer Res 73 2013 439 449
16. V.M. Golubovskaya, K. Conway-Dorsey, and S.N. Edmiston FAK overexpression and p53 mutations are highly correlated in human breast cancer Int J Cancer 125 2009 1735 1738
17. A.L. Lark, C.A. Livasy, and L. Dressler High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype Mod Pathol 18 2005 1289 1294
18. E. Mayordomo, I. Machado, and F. Giner A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models Appl Immunohistochem Mol Morphol 18 2010 453 461
19. O. Stepien, Y. Zhang, and D. Zhu Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma Gut 48 2001 87 96
20. D.W. Van der Schaft, R.E. Seftor, and E.A. Seftor Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells J Natl Cancer Inst 96 2004 1473 1477
21. M.J. Hendrix, E.A. Seftor, and A.R. Hess Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma Nat Rev Cancer 3 2003 411 421
22. A. Sakamoto, and Y. Iwamoto Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy Rev Recent Clin Trials 3 2008 228 231
23. H.S. Kim, S.J. Lim, and Y.K. Park Anti-angiogenic factor endostatin in osteosarcoma APMIS 117 2009 716 723
24. Z. Chen, Q.X. Chen, and Z.Y. Hou Clinical predictive value of serum angiogenic factor in patients with osteosarcoma Asian Pac J Cancer Prev 13 2012 4823 4826
25. D. Fu, X. He, and S. Yang Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro BMC Musculoskelet Disord 12 2011 146 153
26. J. Mei, Y. Gao, and L. Zhang VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro Exp Oncol 30 2008 29 34
27. J.C. Fanburg-Smith, G.L. Bratthauer, and M. Miettinen Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases Hum Pathol 30 1999 32 38
28. J. Xu, S. Wu, and X. Shi Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma J Orthop Res 28 2010 1621 1625
29. J.S. Whelan, R.C. Jinks, and A. McTiernan Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials Ann Oncol 23 2012 1607 1616
30. M.S. Kim, S.Y. Lee, and T.R. Lee Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma Ann Oncol 20 2009 955 960
31. X.S. Lu, W. Sun, and C.Y. Ge Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas Int J Oncol 42 2013 2103 2115
32. J. Halder, H.S. Kim, and P. Vivas-Mejia Dual targeting of EphA2 and FAK in ovarian carcinoma Cancer Biol Ther 8 2009 1027 1034
33. H. Haskell, M. Natarajan, and T.P. Hecker Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells Clin Cancer Res 9 2003 2157 2165
34. R.W. Tilghman, J.K. Slack-Davis, and N. Sergina Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells J Cell Sci 118 2005 2613 2623
35. S. Crouch, C.S. Spidel, and J.S. Lindsey HGF and ligation of αvβ5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering Exp Cell Res 292 2004 274 287